Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

27-Dec-17 - 25-Dec-18
Buy Ratio:33%

Down

# Net Buyers:100
# Net Sellers:202

Previous 52 Weeks

28-Dec-16 - 26-Dec-17
Buy Ratio:41%
# Net Buyers:134
# Net Sellers:196
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Mylan N.V.($18.48M)$1.81B  
Kite Pharma, Inc.--$743.41M  
Corium International, Inc.$304.33M$300.37M  
Seattle Genetics Inc /wa$251.94M$276.59M  
Bausch Health Companies Inc.$2.63M$182.79M  
New Net Buyers
CompanyNet Buy AmountChange
Seattle Genetics Inc /wa$251.94M$276.59M  
Bausch Health Companies Inc.$2.63M$182.79M  
Portola Pharmaceuticals Inc$4.68M$102.04M  
Esperion Therapeutics, Inc.$13.83M$63.64M  
Kalvista Pharmaceuticals, Inc.$18.91M$41.59M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Juno Therapeutics, Inc.($1.27B)($1.05B)  
Colucid Pharmaceuticals, Inc.--($716.17M)  
Lilly Eli & Co($515.28M)($318.38M)  
Alexion Pharmaceuticals, Inc.($5.45M)($225.71M)  
Loxo Oncology, Inc.($322.80M)($191.20M)  
New Net Sellers
CompanyNet Buy AmountChange
Alexion Pharmaceuticals, Inc.($5.45M)($225.71M)  
Madrigal Pharmaceuticals, Inc.($138.13M)($138.28M)  
Acorda Therapeutics Inc($73.79M)($87.53M)  
Steadymed Ltd.($69.27M)($79.17M)  
Diplomat Pharmacy, Inc.($50.62M)($50.84M)